vs

Side-by-side financial comparison of Krystal Biotech, Inc. (KRYS) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

Ribbon Communications Inc. is the larger business by last-quarter revenue ($162.6M vs $107.1M, roughly 1.5× Krystal Biotech, Inc.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs 48.0%, a 6.8% gap on every dollar of revenue. On growth, Krystal Biotech, Inc. posted the faster year-over-year revenue change (17.5% vs -10.3%). Over the past eight quarters, Krystal Biotech, Inc.'s revenue compounded faster (53.8% CAGR vs -8.1%).

Krystal Biotech, Inc. is a clinical-stage biotechnology company specializing in the research, development and commercialization of novel gene therapies for rare, serious dermatological diseases with high unmet medical needs. It primarily serves patients across North America and Europe, focusing on monogenic skin disorders that lack effective standard treatment options.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

KRYS vs RBBN — Head-to-Head

Bigger by revenue
RBBN
RBBN
1.5× larger
RBBN
$162.6M
$107.1M
KRYS
Growing faster (revenue YoY)
KRYS
KRYS
+27.8% gap
KRYS
17.5%
-10.3%
RBBN
Higher net margin
RBBN
RBBN
6.8% more per $
RBBN
54.8%
48.0%
KRYS
Faster 2-yr revenue CAGR
KRYS
KRYS
Annualised
KRYS
53.8%
-8.1%
RBBN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KRYS
KRYS
RBBN
RBBN
Revenue
$107.1M
$162.6M
Net Profit
$51.4M
$89.1M
Gross Margin
42.9%
Operating Margin
41.5%
37.6%
Net Margin
48.0%
54.8%
Revenue YoY
17.5%
-10.3%
Net Profit YoY
13.0%
EPS (diluted)
$1.69
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRYS
KRYS
RBBN
RBBN
Q1 26
$162.6M
Q4 25
$107.1M
$227.3M
Q3 25
$97.8M
$215.4M
Q2 25
$96.0M
$220.6M
Q1 25
$88.2M
$181.3M
Q4 24
$91.1M
$251.4M
Q3 24
$83.8M
$210.2M
Q2 24
$70.3M
$192.6M
Net Profit
KRYS
KRYS
RBBN
RBBN
Q1 26
$89.1M
Q4 25
$51.4M
Q3 25
$79.4M
$-12.1M
Q2 25
$38.3M
$-11.1M
Q1 25
$35.7M
$-26.2M
Q4 24
$45.5M
Q3 24
$27.2M
$-13.4M
Q2 24
$15.6M
$-16.8M
Gross Margin
KRYS
KRYS
RBBN
RBBN
Q1 26
42.9%
Q4 25
53.3%
Q3 25
50.1%
Q2 25
49.6%
Q1 25
45.4%
Q4 24
55.7%
Q3 24
52.1%
Q2 24
50.8%
Operating Margin
KRYS
KRYS
RBBN
RBBN
Q1 26
37.6%
Q4 25
41.5%
4.1%
Q3 25
42.3%
1.3%
Q2 25
40.9%
1.9%
Q1 25
41.0%
-10.8%
Q4 24
45.4%
13.2%
Q3 24
26.8%
-0.4%
Q2 24
12.2%
-1.0%
Net Margin
KRYS
KRYS
RBBN
RBBN
Q1 26
54.8%
Q4 25
48.0%
Q3 25
81.2%
-5.6%
Q2 25
39.9%
-5.0%
Q1 25
40.5%
-14.5%
Q4 24
49.9%
Q3 24
32.4%
-6.4%
Q2 24
22.2%
-8.7%
EPS (diluted)
KRYS
KRYS
RBBN
RBBN
Q1 26
$0.50
Q4 25
$1.69
$0.50
Q3 25
$2.66
$-0.07
Q2 25
$1.29
$-0.06
Q1 25
$1.20
$-0.15
Q4 24
$1.53
$0.05
Q3 24
$0.91
$-0.08
Q2 24
$0.53
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRYS
KRYS
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$496.3M
$67.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$419.1M
Total Assets
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRYS
KRYS
RBBN
RBBN
Q1 26
$67.6M
Q4 25
$496.3M
$96.4M
Q3 25
$392.6M
$74.8M
Q2 25
$353.8M
$60.5M
Q1 25
$308.8M
$71.2M
Q4 24
$344.9M
$87.8M
Q3 24
$374.0M
$37.2M
Q2 24
$345.8M
$64.6M
Total Debt
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
$342.1M
Q3 25
$344.3M
Q2 25
$346.5M
Q1 25
$347.4M
Q4 24
$348.3M
Q3 24
$349.1M
Q2 24
$350.0M
Stockholders' Equity
KRYS
KRYS
RBBN
RBBN
Q1 26
$419.1M
Q4 25
$1.2B
$449.0M
Q3 25
$1.1B
$360.1M
Q2 25
$1.0B
$370.4M
Q1 25
$984.7M
$381.8M
Q4 24
$946.4M
$404.6M
Q3 24
$885.8M
$395.5M
Q2 24
$838.9M
$405.0M
Total Assets
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
$1.3B
$1.2B
Q3 25
$1.2B
$1.1B
Q2 25
$1.1B
$1.1B
Q1 25
$1.1B
$1.1B
Q4 24
$1.1B
$1.2B
Q3 24
$982.3M
$1.1B
Q2 24
$917.7M
$1.1B
Debt / Equity
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
0.76×
Q3 25
0.96×
Q2 25
0.94×
Q1 25
0.91×
Q4 24
0.86×
Q3 24
0.88×
Q2 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRYS
KRYS
RBBN
RBBN
Operating Cash FlowLast quarter
$77.5M
Free Cash FlowOCF − Capex
$75.4M
FCF MarginFCF / Revenue
70.4%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$188.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
$77.5M
$29.2M
Q3 25
$39.7M
$26.5M
Q2 25
$52.7M
$-795.0K
Q1 25
$31.0M
$-3.5M
Q4 24
$52.8M
$61.8M
Q3 24
$58.9M
$-14.8M
Q2 24
$-4.2M
$-9.8M
Free Cash Flow
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
$75.4M
$27.3M
Q3 25
$38.0M
$21.0M
Q2 25
$50.8M
$-6.5M
Q1 25
$24.8M
$-15.7M
Q4 24
$52.0M
$53.8M
Q3 24
$57.8M
$-23.7M
Q2 24
$-5.3M
$-12.9M
FCF Margin
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
70.4%
12.0%
Q3 25
38.8%
9.7%
Q2 25
52.9%
-2.9%
Q1 25
28.1%
-8.7%
Q4 24
57.1%
21.4%
Q3 24
69.0%
-11.3%
Q2 24
-7.5%
-6.7%
Capex Intensity
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
2.0%
0.9%
Q3 25
1.7%
2.6%
Q2 25
2.0%
2.6%
Q1 25
7.0%
6.7%
Q4 24
0.9%
3.2%
Q3 24
1.2%
4.2%
Q2 24
1.6%
1.6%
Cash Conversion
KRYS
KRYS
RBBN
RBBN
Q1 26
Q4 25
1.51×
Q3 25
0.50×
Q2 25
1.38×
Q1 25
0.87×
Q4 24
1.16×
Q3 24
2.17×
Q2 24
-0.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRYS
KRYS

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons